The 5-HT(1A) and 5-HT(2A/2C) receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced Fos expression in the brain

Brain Research

Volumn 791, Issue 1-2, 1998, Pages 67-74

  Javed, A ^a   Van De Kar, L D ^a   Gray, T S ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

5 Hydroxytryptamine; Amygdala; Bed nucleus; Brainstem; Caudate putamen; Cortex; Paraventricular nucleus

Indexed keywords

DEXFENFLURAMINE; DRUG VEHICLE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PROTEIN C FOS; RITANSERIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; SODIUM CHLORIDE; FENFLURAMINE; NERVE PROTEIN; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN STEM; CAUDATE NUCLEUS; CINGULATE GYRUS; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; GENE EXPRESSION; HYPOTHALAMUS; IMMEDIATE EARLY GENE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PUTAMEN; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; BIOSYNTHESIS; BRAIN; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; FENFLURAMINE; MALE; NERVE TISSUE PROTEINS; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032571598     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00082-1     Document Type: Article

References (65)

1. Abel K.M., O'Keane V., Murray R.M. Enhancement of the prolactin response to D-fenfluramine in drug-naive schizophrenic patients. Br. J. Psychiat. 168:1996;57-60.
2. 1C receptors in rat brain. J. Pharmacol. Exp. Ther. 255:1990;843-857.
3. Bancroft J., Cook A. The neuroendocrine response to D-fenfluramine in women with premenstrual depression. J. Affect. Disord. 36:1995;57-64.
4. 4-like receptor expressed in bovine pulmonary artery smooth muscle cells. Mol. Pharmacol. 42:1992;817-825.
5. Bullitt E. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J. Comp. Neurol. 296:1990;517-530.
6. 1A binding in rat brain - a combined in situ hybridization/in vivo receptor autoradiography study. Brain Res. 561:1991;51-60.
7. Claeysen S., Sebben M., Journot L., Bockaert J., Dumuis A. Cloning, expression and pharmacology of the mouse 5-HT(4L) receptor. FEBS Lett. 398:1996;19-25.
8. Cleare A.J., Bearn J., Allain T., McGregor A., Wessely S., Murray R.M., O'Keane V. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J. Affect. Disord. 34:1995;283-289.
9. Cleare A.J., Bond A.J. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Psychiatr. Res. 69:1997;89-95.
10. Coccaro E.F., Berman M.E., Kavoussi R.J., Hauger R.L. Relationship of prolactin response to D-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol. Psychiatr. 40:1996;157-164.
11. 1A receptor antagonist WAY100635. Eur. J. Pharmacol. 264:1994;95-97.
12. 2 receptors throughout the rat central nervous system using quantitative autoradiography. Brain Res. 421:1987;263-279.
13. 1A receptor antagonist. Behav. Brain Res. 73:1995;337-353.
14. 6 receptor-like material in the rat central nervous system. Brain Res. 746:1997;207-219.
15. 6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse. 23:1996;164-173.
16. Ginefri-Gayet M., Gayet J. Possible link between brain serotonin metabolism and methionine sulfoximine-induced hypothermia and associated behavior in the rat. Pharmacol. Biochem. Behav. 43:1992;173-179.
17. 1A receptor agonists. Brain Res. 638:1994;235-242.
18. Gotoh E., Murakami K., Bahnson T.D., Ganong W.F. Role of brain serotonergic pathways and hypothalamus in regulation of renin secretion. Am. J. Physiol. 253:1987;R179-R185.
19. Grignaschi G., Samanin R. Role of 5-HT receptors in the effect of D-fenfluramine on feeding patterns in the rat. Eur. J. Pharmacol. 212:1992;287-289.
20. 1A receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo. Br. J. Pharmacol. 112:1994;299P.
21. Handa R.J., Cross M.K., George M., Gordon B.H., Burgess L.H., Cabrera T.M., Hata N., Campbell D.B., Lorens S.A. Neuroendocrine and neurochemical responses to novelty stress in young and old male F344 rats: Effects of D-fenfluramine treatment. Pharmacol. Biochem. Behav. 46:1993;101-109.
22. Hetem L.A., de Souza C.J., Guimaraes E.S., Zuardi A.W., Graeff F.G. Effect of D-fenfluramine on human experimental anxiety. Psychopharmacology. 127:1996;276-282.
23. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
24. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47:1995;133-178.
25. A. Javed, L.D. van De Kar, T.S. Gray, p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions, Brain Res., 1997, in press.
26. 1A receptor antagonist. Brain Res. 673:1995;217-225.
27. 6 serotonin receptor. J. Neurochem. 66:1996;47-56.
28. Leslie R.A., Moorman J.M., Coulson A., Grahame-Smith D.G. Serotonin 2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibers. Neuroscience. 53:1993;457-463.
29. 1A agonist, 8-OH-DPAT. Neuropharmacology. 33:1994;335-342.
30. Li B., Rowland N.E. Dexfenfluramine induces fos-like immunoreactivity in discrete brain regions in rats. Brain Res. Bull. 31:1993;43-48.
31. Li B., Rowland N.E. Effect of chronic dexfenfluramine on Fos in rat brain. Brain Res. 728:1996;188-192.
32. Lucey J.V., Butcher G., Clare A.W., Dinan T.G. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit. Acta Psychiatr. Scand. 87:1993;384-388.
33. 2 antagonist ritanserin on food intake and on 5-HT-induced anorexia in the rat. Pharmacol. Biochem. Behav. 26:1987;333-340.
34. McTavish D., Heel R.C. Dexfenfluramine: A review of its pharmacological properties and therapeutic potential in obesity. Drugs. 43:1992;713-733.
35. Miquel M.-C., Doucet E., Boni C., el Mestikawy S., Matthiessen L., Daval G., Verge D., Hamon M. Central serotonin 1A receptors: respective distributions of encoding mRNA receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem. Int. 19:1991;453-465.
36. Monteleone P., Catapano F., Tortorella A., Maj M. Cortisol response to D-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect. Neuropsychobiology. 36:1997;8-12.
37. Moorman J.M., Leslie R.A. p-Chloroamphetamine induces c-fos in rat brain: a study of serotonin 2A/2C receptor function. Neuroscience. 72:1996;129-139.
38. 1A receptor mechanisms in the inhibitory effects of methamphetamine on photic responses in the rodent suprachiasmatic nucleus. Brain Res. 740:1996;261-267.
39. 3H]serotonin from rat brain synaptosomes. J. Med. Chem. 25:1984;530-534.
40. G. Paxinos, C. Watson (Eds.), The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
41. 2A/2C) receptors. J. Pharm. Exp. Ther. 271:1994;1647-1655.
42. Rowland N.E. Effects of continuous infusions of dexfenfluramine on food intake, body weight and brain amines in rats. Life Sci. 39:1986;2581-2586.
43. 7) activating cAMP formation. Proc. Natl. Acad. Sci. 90:1993;8547-8551.
44. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
45. 2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat. Neuropharmacology. 28:1989;465-469.
46. Saydoff J.A., Rittenhouse P.A., Carnes M., Armstrong J., Van De Kar L.D., Brownfield M.S. Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin. Am. J. Physiol. 270:1996;E513-21.
47. Schotte A., De Bruyckere K., Janssen P.F.M., Leysen J.E. Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography. Brain Res. 500:1989;295-301.
48. 6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture. Neuroreport. 5:1994;2553-2557.
49. Series H.G., Cowen P.J., Sharp T. p-Chloroamphetamine (PCA), 3,4-methylendioxymethamphetamine (MDMA) and D-fenfluramine pretreatment attenuate D-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology. 116:1994;508-514.
50. 7 serotonin receptor subtype. J. Biol. Chem. 24:1993;18200-18204.
51. Shor-Posner G., Grinker J.A., Marinescu C., Brown O., Leibowitz S.F. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res. Bull. 17:1986;663-671.
52. 7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol. Pharmacol. 47:1995;99-103.
53. Storlien L.H., Smythe G.A. D-Fenfluramine effects on hypothalamic monoamine activities and their hormonal correlates. Brain Res. 597:1992;60-65.
54. Thakore J.H., Dinan T.G. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol. Psychiatr. 37:1995;364-368.
55. Thakore J.H., O'Keane V., Dinan T.G. D-Fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity. Am. J. Psychiatr. 153:1996;1460-1463.
56. 2A/2C receptor activation is differentially regulated in four regions of rat brain. Eur. J. Pharmacol. 307:1996;211-217.
57. 7 receptor positively coupled to adenylyl cyclase. J. Neurochem. 63:1994;456-464.
58. 4 receptor mRNA in the rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 354:1996;210-212.
59. Van De Kar L.D., Rittenhouse P.A., Li Q., Levy A.D., Brownfield M.S. Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Res. Bull. 36:1994;45-50.
60. Van Nueten J.M., Schuurkes J.A.J., De Ridder W.J.E., Kuyps J.J.M.D., Janssens W.J. Comparative pharmacological profile of ritanserin and ketanserin. Drug Dev. Res. 8:1986;187-195.
61. A. Vicentic, Q. Li, G. Battaglia, L.D. Van De Kar, WAY-100635 inhibits 8-OH-DPAT stimulated oxytocin, ACTH and corticosterone but not prolactin secretion, Eur. J. Pharmacol., 1997, in press.
62. 1A receptor subtype. Psychopharmacology. 125:1996;168-175.
63. 4 receptor mRNA in rat brain by in situ hybridization histochemistry. Mol. Brain Res. 43:1996;356-360.
64. Weiss G.F., Papadakos P., Knudson K., Leibowitz S.F. Medial hypothalamic serotonin: effects on deprivation and norepinephrine-induced eating. Pharmacol. Biochem. Behav. 25:1986;1223-1230.
65. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.